Compare PCT & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCT | INVA |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | 174 | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2000 |
| Metric | PCT | INVA |
|---|---|---|
| Price | $7.36 | $22.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $13.00 | ★ $32.80 |
| AVG Volume (30 Days) | ★ 7.0M | 750.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 2.22 |
| Revenue | N/A | ★ $217,217,000.00 |
| Revenue This Year | $380.44 | $8.95 |
| Revenue Next Year | $203.33 | $12.65 |
| P/E Ratio | ★ N/A | $10.00 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $4.93 | $16.52 |
| 52 Week High | $17.37 | $25.15 |
| Indicator | PCT | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 35.55 | 46.21 |
| Support Level | $5.02 | $21.51 |
| Resistance Level | $9.56 | $23.03 |
| Average True Range (ATR) | 0.49 | 0.64 |
| MACD | -0.04 | -0.09 |
| Stochastic Oscillator | 16.10 | 20.45 |
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.